Ferronordic reported a mixed set of Q4 2024 numbers, with sales clearly beating our expectation, lar...
Next milestones: finalisation of environmental permit.
Germany weaker than expected, US stronger We make more cuts in Germany High leverage is the bottlene...
We expect positive organic growth from H2'25 EBIT estimates cut 2%, mainly on FX Share is trading at...
Aktiemarknaden verkar ha haft högre förväntningar med tanke på dagens kursreaktion, men ur vårt pers...
Redeye provides a research update following the Q4 report published by Cinclus earlier today.
Zoomability publicerade den 20 februari 2025 bolagets delårsrapport för årets fjärde kvartal 2024.
Försiktigheten består Nettoomsättningen minskade med 20,8 procent, där den största överraskningen va...
Redeye provides a research update following the Q4 report published by OncoZenge earlier today.
Prostatype Genomics har kompletterat sin ansökan om att inkluderas i det amerikanska ersättningssyst...
Marimekko ended its year on a high note as Q4 figures were better than we expected for both sales an...
Redeye is positive to the news that EMA has returned with positive feedback to IRLAB’s phase III pla...
Nosa Plugs AB ("Nosa Plugs" or the "Company") is a medical technology company that has developed int...
Redeye’s comments on Xbrane following its year-end report, which showed negative revenue growth both...
Redeye provides its initial take on Navigo’s Q4 2024 report, which beat our sales estimate but misse...
